Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience

類似資料

• Palbociclib in metastatic breast cancer: current evidence and real-life data
  著者:: Serra, Francesco, 等
  出版事項: (2019)
• Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study
  著者:: Palumbo, Raffaella, 等
  出版事項: (2021)
• Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
  著者:: Palumbo, Raffaella, 等
  出版事項: (2015)
• Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
  著者:: Barbara Tagliaferri, 等
  出版事項: (2020-09-01)
• Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
  著者:: Tagliaferri, Barbara, 等
  出版事項: (2020)